Emerging nanotaxanes for cancer therapy

This publication has 233 references indexed in Scilit:

• Paclitaxel-hyaluronan hydrosoluble bioconjugate: Mechanism of action in human bladder cancer cell lines
  Urologic Oncology: Seminars and Original Investigations, 2013
• Clinical and economic implications of the use of nanoparticle paclitaxel (Nanoxel) in India
  Annals of Oncology, 2013
• Enhanced Oral Delivery of Paclitaxel Using Acetylcysteine Functionalized Chitosan-Vitamin E Succinate Nanomicelles Based on a Mucus Bioadhesion and Penetration Mechanism
  Molecular Pharmaceutics, 2013
• Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer
  Biomaterials, 2013
• Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance
  Biomaterials, 2011
• Hyaluronic acid–paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism
  Oral Oncology, 2011
• Paclitaxel-Loaded Expansile Nanoparticles Delay Local Recurrence in a Heterotopic Murine Non-Small Cell Lung Cancer Model
  The Annals of Thoracic Surgery, 2011
• Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma
  Annals of Oncology, 2010
• Cabazitaxel
  Nature Reviews Drug Discovery, 2010
• Paclitaxel poliglumex
  Drugs of the Future, 2007